DK638989D0 - Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser - Google Patents

Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser

Info

Publication number
DK638989D0
DK638989D0 DK638989A DK638989A DK638989D0 DK 638989 D0 DK638989 D0 DK 638989D0 DK 638989 A DK638989 A DK 638989A DK 638989 A DK638989 A DK 638989A DK 638989 D0 DK638989 D0 DK 638989D0
Authority
DK
Denmark
Prior art keywords
beta
tgf
cells
cell lines
growth factor
Prior art date
Application number
DK638989A
Other languages
English (en)
Other versions
DK638989A (da
Inventor
Anthony F Purchio
Daniel Twardzik
Larry Gentry
Amy M Brunner
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of DK638989D0 publication Critical patent/DK638989D0/da
Publication of DK638989A publication Critical patent/DK638989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Eletrric Generators (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
DK638989A 1988-12-16 1989-12-15 Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser DK638989A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28591788A 1988-12-16 1988-12-16
US35017189A 1989-04-17 1989-04-17
US35372889A 1989-05-17 1989-05-17

Publications (2)

Publication Number Publication Date
DK638989D0 true DK638989D0 (da) 1989-12-15
DK638989A DK638989A (da) 1990-06-17

Family

ID=27403570

Family Applications (1)

Application Number Title Priority Date Filing Date
DK638989A DK638989A (da) 1988-12-16 1989-12-15 Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser

Country Status (16)

Country Link
EP (1) EP0373994B1 (da)
JP (1) JPH03130089A (da)
KR (1) KR900009985A (da)
CN (1) CN1044125A (da)
AT (1) ATE118546T1 (da)
AU (1) AU638952B2 (da)
CA (1) CA2003886A1 (da)
DE (1) DE68921167T2 (da)
DK (1) DK638989A (da)
ES (1) ES2070924T3 (da)
FI (1) FI895730A0 (da)
IE (1) IE67811B1 (da)
IL (1) IL92489A0 (da)
NO (1) NO179676C (da)
NZ (1) NZ231581A (da)
PT (1) PT92454B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293785A3 (en) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
US5304541A (en) * 1988-12-15 1994-04-19 Bristol-Myers Squibb Company Methods using novel chimeric transforming growth factor-β1/β2
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6942853B2 (en) 2001-01-09 2005-09-13 Queen Mary And Westfield College Latent fusion protein
US7141392B2 (en) 2001-01-09 2006-11-28 Queen Mary And Westfield College Latent fusion protein
EP1279740A1 (en) * 2001-07-26 2003-01-29 Vrije Universiteit Brussel Recombinant vector derived from adeno-associated virus for gene therapy
WO2005068499A1 (en) * 2004-01-06 2005-07-28 The Government Of The United States As Representedby The Secretary, Department Of Health & Human Services Compositions and methods for the high efficiency expression of the transforming growth factor-beta supergene family
WO2012055541A1 (en) * 2010-10-25 2012-05-03 Bavarian Nordic A/S Tgf-beta in the development of conventional dendritic cells and uses thereof
CN104311631A (zh) * 2014-09-28 2015-01-28 苏州普罗达生物科技有限公司 转化生长因子β1激动剂多肽及其制备方法、应用
CN104211778A (zh) * 2014-09-28 2014-12-17 苏州普罗达生物科技有限公司 一种转化生长因子β1激动剂多肽及其制备方法、应用
RU2652312C2 (ru) * 2016-01-20 2018-04-25 Селл энд Джин Терапи Лтд Линейка биологически активных генно-терапевтических субстанций на основе гена tgfb1 для коррекции патологических состояний клеток органов и тканей и органов и тканей человека, способ получения и использования

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
EP0293785A3 (en) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
CA2005120A1 (en) * 1988-12-15 1990-06-15 Anthony F. Purchio Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
CA2014699A1 (en) * 1989-04-20 1990-10-20 The Lubrizol Corporation Methods for reducing friction between relatively slideable components using metal overbased colloidal disperse systems

Also Published As

Publication number Publication date
IE893779L (en) 1990-06-16
CN1044125A (zh) 1990-07-25
ATE118546T1 (de) 1995-03-15
NO894759L (no) 1990-06-18
AU638952B2 (en) 1993-07-15
NO894759D0 (no) 1989-11-29
NO179676B (no) 1996-08-19
IL92489A0 (en) 1990-08-31
NZ231581A (en) 1993-01-27
CA2003886A1 (en) 1990-06-16
DE68921167T2 (de) 1995-06-01
DE68921167D1 (de) 1995-03-23
AU4588289A (en) 1990-06-21
IE67811B1 (en) 1996-05-01
FI895730A0 (fi) 1989-11-29
EP0373994A1 (en) 1990-06-20
EP0373994B1 (en) 1995-02-15
PT92454B (pt) 1995-07-18
KR900009985A (ko) 1990-07-06
DK638989A (da) 1990-06-17
PT92454A (pt) 1990-06-29
ES2070924T3 (es) 1995-06-16
NO179676C (no) 1996-11-27
JPH03130089A (ja) 1991-06-03

Similar Documents

Publication Publication Date Title
EP0293785A3 (en) Cloning and expression of simian transforming growth factor-ss1
DK638989D0 (da) Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser
ES2324046T5 (es) Procedimiento para controlar la sialilación de proteínas producidas por un cultivo de células de mamíferos
ES2266159T3 (es) Mejora de la galactosilacion de glicoproteinas recombinantes.
ATE127518T1 (de) Mikrobisch-produziertes rinderwachstumshormon und dessen verwendung.
ES2333724T3 (es) Secuencias lideres para uso en la produccion de proteinas.
US7282352B2 (en) Homogeneity and secretion of recombinant proteins in mammalian systems
US6693181B2 (en) Protein secretion
BR9905867A (pt) Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
EP0349598A1 (en) Method for stimulating gene expression
AU744484B2 (en) Method for increasing secretion of proteins in eukaryotic host cells
RU2670889C1 (ru) Способ контроля гликозилирования рекомбинантного гликопротеина
CA2113076A1 (en) Recombinant human interleukin 6 with homogeneous n-terminus and production thereof
CA2297660A1 (en) Production of human mutated proteins in human cells by means of homologous recombination

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment